Navigation Links
Cure for common cold,,

The cure for the common cold remains as elusive as ever. A federal advisory committee recommended recently that the first drug aimed at treating the cause of the cold// rather than just its symptoms not be approved.

In a unanimous decision, the Food and Drug Administration’s advisory panel on anti-viral drugs said there were too many questions about the safety of the drug, which is made by ViroPharma Inc., to allow its widespread use merely to treat an ail-away by itself. The drug, known as Picovir, has attracted attention because it directly attacks a family of viruses, known as picornavirus, that cause half or more of the billion colds caught in the US each year. The drug lodges into a pocket in the virus’ coat, interfering with the germ’s ability to infect cells and make copies of itself. Other cold remedies merely suppress symptoms, like drying runny noses or coughs. In clinical trials, Picovir shortened the length of the cold to roughly six days from seven. Patients took the pills three times a day for five days. First treatment, however, has to start within 24 hours of onset of symptoms, which some panel members said might be difficult for a drug that would be sold by prescription. The major concern, was that Picovir appeared to lower the effectiveness of oral contraceptives, which might cause inadvertent pregnancies. Some women taking both Picovir and birth control pills experienced bleeding between their menstrual periods. The panel also questioned whether the drug could be used by the general population because the participants in the clinical trial were mainly young, white, otherwise healthy women.

'"/>




Page: 1

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Iron supplementation for a common side effect
3. E. coli strains resistant to a common antibiotic
4. Gastrointestinal ills more common in diabetics
5. Toxic effects common with AIDS treatments
6. Drooping eyelids more common in men
7. Unnatural death common in mentally ill
8. New Drug, Pleconaril speeds recovery from common cold
9. Relief from common back pain
10. Drugs control and industry departments to share a common e-platform
11. Periodontitis a common problem in patients with arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... 04, 2016 , ... Nike Rugby Camp's success is due in large part ... of Elite Rugby Camps and current Nike Camp director, has offered an all abilities ... , “I’m excited for our eighth summer here in San Diego,” says Willis. "We ...
(Date:5/4/2016)... ... 2016 , ... All-Star Insurance of Northeast TX has announced ... their local community. The agency pledges to select a new beneficiary every 60 ... bring awareness to important local causes with fundraising and other support, by forming ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, ... at their office. Wisdom tooth removal, a common dental procedure, is performed for many ... are improperly erupted, resulting in risks of complications. By providing wisdom tooth removal surgery ...
(Date:5/4/2016)... ... , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car ... procedure at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses ... day as her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... small and compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and ... NSP-9842XL (average retail starting at $59.95) uses 2 included CR-123 batteries to produce ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis ... of two patients who tell their personal story and encourage those at risk to get ... Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... -- Forté Elements, LLC (Forté) is excited to announce the launch of its Mediceutical line ... of recovery for a variety of clinical conditions. Founded in 2013, Forté spent more ... Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
Breaking Medicine Technology: